Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
出版年份 2011 全文链接
标题
Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 20, Issue 10, Pages 1357-1375
出版商
Informa Healthcare
发表日期
2011-09-13
DOI
10.1517/13543784.2011.614230
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies
- (2011) David S. Hong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Targeted therapy of thyroid cancer
- (2010) Steven I. Sherman BIOCHEMICAL PHARMACOLOGY
- Follow-up of patients treated with retinoic acid for the control of radioiodine non-responsive advanced thyroid carcinoma
- (2010) S.M. Coelho et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells
- (2010) M. Todaro et al. CANCER RESEARCH
- Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
- (2010) R.C. Smallridge et al. CLINICAL ONCOLOGY
- A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer
- (2010) M A Trujillo et al. GENE THERAPY
- The Feasibility Study of Docetaxel in Patients with Anaplastic Thyroid Cancer
- (2010) K. Kawada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- High Efficacy of Concomitant Treatment of Undifferentiated (Anaplastic) Thyroid Cancer with Radiation and Docetaxel
- (2010) Marlene Troch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Profound Hair and Skin Hypopigmentation in an African American Woman Treated With the Multi-Targeted Tyrosine Kinase Inhibitor Pazopanib
- (2010) Kostandinos Sideras et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
- (2010) Elaine T. Lam et al. JOURNAL OF CLINICAL ONCOLOGY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
- (2010) Keith C Bible et al. LANCET ONCOLOGY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
- (2010) A. R. Tan et al. ONCOLOGIST
- Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy
- (2010) Robert L. Foote et al. THYROID
- DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
- (2009) Melissa J LaBonte et al. BMC Medical Genomics
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005
- (2009) Amy Y. Chen et al. CANCER
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005
- (2009) L. Enewold et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors
- (2009) KATHLEEN J. SMITH et al. DERMATOLOGIC SURGERY
- Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis
- (2009) Cristina Rodríguez-Antona et al. ENDOCRINE-RELATED CANCER
- Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma
- (2009) Hendrieke Hoftijzer et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Dual Inhibition of Mitogen-Activated Protein Kinase Kinase and Mammalian Target of Rapamycin in Differentiated and Anaplastic Thyroid Cancer
- (2009) Ning Jin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Induction of Thyroid Gene Expression and Radioiodine Uptake in Thyroid Cancer Cells by Targeting Major Signaling Pathways
- (2009) Peng Hou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
- (2009) Martin J. Schlumberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Keratoacanthomas and Squamous Cell Carcinomas in Patients Receiving Sorafenib
- (2009) Jean Philippe Arnault et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Metastatic Thyroid Cancer
- (2009) Richard T. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with Outcome
- (2009) Colin J. Mooney et al. THYROID
- Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect
- (2008) M Peled et al. CANCER GENE THERAPY
- Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
- (2008) Robert C Smallridge et al. ENDOCRINE-RELATED CANCER
- Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers
- (2008) Zhi Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study
- (2008) Ezra E.W. Cohen et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Sorafenib in Advanced Thyroid Cancer
- (2008) Vandana Gupta-Abramson et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers
- (2008) Alex A. Adjei et al. JOURNAL OF CLINICAL ONCOLOGY
- Thyroid carcinoma: molecular pathways and therapeutic targets
- (2008) Yuri E Nikiforov MODERN PATHOLOGY
- Motesanib Diphosphate in Progressive Differentiated Thyroid Cancer
- (2008) Steven I. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started